CanAg Diagnostics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 79

Employees

  • Latest Deal Type
  • M&A

CanAg Diagnostics General Information

Description

Developer of immunological reagents. The company develops monoclonal antibodies for the treatment of cancer, brain damage and tumors.

Contact Information

Website
www.canag.se
Formerly Known As
Centocor Diagnostics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Elof Lindälvs gata 13
  • 414 55 Gothenburg
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Fujirebio Diagnostics
Corporate Office
  • Elof Lindälvs gata 13
  • 414 55 Gothenburg
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CanAg Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-May-2006 Completed Generating Revenue
2. Angel (individual) 01-Jan-2001 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view CanAg Diagnostics’s complete valuation and funding history, request access »

CanAg Diagnostics Patents

CanAg Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070037180-A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpv's Inactive 10-Feb-2005
ES-2376167-T3 Immuno tests for the specific determination of scca isoforms. Inactive 10-Sep-2002
CA-2498524-A1 Immunoassays for specific determination of scca isoforms Active 10-Sep-2002
US-20080057520-A1 Monoclonal antibody for detecting squamous cell carcinoma antigen (scca); diagnostic indicator for cancer screening; immunodiagnostics Inactive 10-Sep-2002
US-20040176577-A1 Monoclonal antibody for classifiying squamous cell carcinoma antigen (scca) species and diagnosis of cell proliferative disorders Inactive 10-Sep-2002 C07K16/30
To view CanAg Diagnostics’s complete patent history, request access »

CanAg Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CanAg Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Industrifonden Venture Capital Minority
Líftæknisjóðurinn MP BIO hf Venture Capital Minority
To view CanAg Diagnostics’s complete investors history, request access »

CanAg Diagnostics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Majira Real Estate 7 Molndal, Sweden 2017

CanAg Diagnostics FAQs

  • When was CanAg Diagnostics founded?

    CanAg Diagnostics was founded in 1992.

  • Where is CanAg Diagnostics headquartered?

    CanAg Diagnostics is headquartered in Gothenburg, Sweden.

  • What is the size of CanAg Diagnostics?

    CanAg Diagnostics has 79 total employees.

  • What industry is CanAg Diagnostics in?

    CanAg Diagnostics’s primary industry is Drug Discovery.

  • Is CanAg Diagnostics a private or public company?

    CanAg Diagnostics is a Private company.

  • What is CanAg Diagnostics’s current revenue?

    The current revenue for CanAg Diagnostics is .

  • Who are CanAg Diagnostics’s investors?

    Industrifonden and Líftæknisjóðurinn MP BIO hf have invested in CanAg Diagnostics.

  • When was CanAg Diagnostics acquired?

    CanAg Diagnostics was acquired on 31-May-2006.

  • Who acquired CanAg Diagnostics?

    CanAg Diagnostics was acquired by Fujirebio Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »